Table 2.
Fatty acid concentrations in the whole serum lipids of the study subjects
| Fatty acid | Controls (μmol/L) | Obese patients (μmol/L) | Obese patients after diet (μmol/L) | Patients with chronic kidney disease (μmol/L) |
|---|---|---|---|---|
| 12:0 | 15.1 ± 1.54 | 24.2 ± 6.49 | 16.4 ± 1.68 | 15.7 ± 1.75 |
| 14:0 | 93.5 ± 9.04 | 188 ± 59.2# | 94.1 ± 7.29 | 115 ± 11.9 |
| 15:0 | 26.1 ± 2.21 | 31.7 ± 6.03 | 25.8 ± 1.71 | 26.8 ± 2.28 |
| 16:0 | 1569 ± 125 | 2393 ± 482# | 1820 ± 92.7 | 1697 ± 156 |
| 17:0 | 23.4 ± 1.78 | 29.7 ± 5.91# | 21.7 ± 1.02 | 28.8 ± 2.68# |
| 18:0 | 525 ± 42.2 | 668 ± 135 | 491 ± 24.7 | 584 ± 69.2 |
| 19:0 | 3.48 ± 0.32 | 3.73 ± 0.78 | 3.08 ± 0.25 | 3.13 ± 0.37 |
| 20:0 | 11 ± 0.84 | 15.8 ± 3.90 | 11.2 ± 0.64 | 13.4 ± 1.40 |
| 21:0 | 3.78 ± 0.34 | 3.65 ± 0.46 | 4.31 ± 0.31 | 3.06 ± 0.29 |
| 22:0 | 17.4 ± 1.12 | 19.6 ± 3.37 | 18.2 ± 1.02 | 16.3 ± 1.58 |
| 23:0 | 6.77 ± 0.54 | 7.38 ± 1.48 | 6.57 ± 0.33 | 6.25 ± 0.85 |
| 24:0 | 16.8 ± 1.09 | 18.1 ± 2.92 | 17.1 ± 0.93 | 14.6 ± 1.24 |
| SFA | 2311 ± 14.9 | 3403 ± 57.7# | 2530 ± 10.3 | 2525 ± 19.7 |
| 14:1 | 4.74 ± 0.66 | 11.6 ± 4.6# | 4.76 ± 0.46 | 6.26 ± 0.81 |
| 16:1 | 206 ± 21.7 | 386 ± 74.9* | 267 ± 22.1 | 265 ± 30.1 |
| 18:1 | 1578 ± 132 | 2445 ± 470# | 1869 ± 107 | 1959 ± 223 |
| 20:1 | 12.0 ± 1.21 | 19.0 ± 4.59 | 13.8 ± 1.06 | 19.5 ± 1.83* |
| 24:1 | 14.2 ± 1.49 | 19.6 ± 3.58 | 14.2 ± 0.74 | 14.2 ± 1.43 |
| MUFA | 1815 ± 31.1 | 2880 ± 110# | 2169 ± 25.3 | 2263 ± 50.5 |
| 18:2n-6 | 1742 ± 127 | 1778 ± 2370 | 1532 ± 91.6 | 1257 ± 107# |
| 20:4n-6 | 376 ± 40.1 | 439 ± 71.9 | 430 ± 22.1 | 230.85 ± 19.8# |
| 20:3n-6 | 82.7 ± 8.01 | 137 ± 18.2* | 92.5 ± 7.39 | 67.2 ± 7.24 |
| 20:2n-6 | 16.1 ± 2.80 | 17.0 ± 1.89 | 12.8 ± 0.97 | 15.2 ± 1.39 |
| 22:5n-6 | 6.26 ± 0.66 | 8.14 ± 1.32 | 6.94 ± 0.46 | 4.23 ± 0.41# |
| 22:4n-6 | 10.7 ± 1.65 | 13.8 ± 2.23 | 10.3 ± 0.65 | 4.88 ± 0.59# |
| PUFAn-6 | 2234 ± 28.9 | 2393 ± 53.8 | 2084 ± 19.1 | 1579 ± 22.1# |
| 18:3n-3 | 19.2 ± 2.26 | 42.5 ± 10.9* | 21.9 ± 2.41 | 15.3 ± 1.70 |
| 20:5n-3 | 59.1 ± 7.34 | 72.2 ± 19.2 | 60.0 ± 6.04 | 53.5 ± 5.09 |
| 20:4n-3 | 8.02 ± 1.08 | 11.6 ± 1.71 | 6.78 ± 0.79 | 8.80 ± 0.96 |
| 22:6n-3 | 96.0 ± 13.1 | 83.7 ± 11.7 | 106 ± 7.95 | 71.5 ± 6.60 |
| 22:5n-3 | 26.5 ± 2.91 | 34.0 ± 5.65 | 25.2 ± 1.63 | 20.6 ± 1.58 |
| PUFAn-3 | 209 ± 5.02 | 244 ± 9.20 | 220 ± 3.17 | 170 ± 2.42 |
Data are presented as mean ± SEM
* p < 0.01; # p < 0.05 indicates a statistically significant difference compared to controls